Thu, October 19, 2023
Wed, October 18, 2023
Tue, October 17, 2023
Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023

Matthew Korn Maintained (BNTX) at Hold with Decreased Target to $110 on, Oct 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-110-on-oct-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Korn of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $116 to $110 on, Oct 17th, 2023.

Matthew has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Yifeng Liu of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $111 on, Monday, October 16th, 2023


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Monday, August 28th, 2023
  • Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $124 on, Friday, July 14th, 2023

Publication Contributing Sources